KATIE SAGAR: Open Payments
NPI 1609647791 · WINCHESTER, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $595 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| Ardelyx, Inc. | 3 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| GENZYME CORPORATION | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Medtronic, Inc. | 1 | $19 |
| Gilead Sciences, Inc. | 1 | $18 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: IBSRELA, XIFAXAN, RINVOQ, MAVYRET, DUPIXENT, REZDIFFRA, SYNCHROMEDII, OCALIVA.
Industry payments across VA — which companies pay providers there.
